PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial | Trials | Full Text
An update on polymyalgia rheumatica - Lundberg - 2022 - Journal of Internal Medicine - Wiley Online Library
Polymyalgia Rheumatica and Steroid Side Effects: New Findings
PDF] Update on treatment of polymyalgia rheumatica. | Semantic Scholar
Neuromuscular Diseases in Geriatric Patients: Part II | Consultant360
PDF] Concise guidance: diagnosis and management of polymyalgia rheumatica. | Semantic Scholar
JKMS :: Journal of Korean Medical Science
What Is Polymyalgia Rheumatica? These Are the Signs You Could Have It
The effect of a nurse-led prednisolone tapering regimen in polymyalgia rheumatica: a retrospective cohort study | SpringerLink
Steroids for Rheumatic Disease and Regional Pain Disorders
Effects of Baseline Prednisone Dose on Remission and Disease Flare in Patients with Giant Cell Arteritis Treated with Tocilizumab in a Phase 3 Randomized Controlled Trial - ACR Meeting Abstracts
Diagnosis and treatment of PMR - UpToDate
2015 Recommendations for the Management of Polymyalgia Rheumatica
Tocilizumab plus prednisone reduces treatment failure risk sixfold in giant cell arteritis
Suggested Treatment Algorithms for the Management of ... | GrepMed
Taper schedule for steroids (dose in mg) | Download Table
Tocilizumab improves GCA outcomes in patients with polymyalgia, cranial symptoms
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial - The Lancet
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity
Tapering off Prednisone for PMR - Dr. Megan
Prednisone Withdrawal: Symptoms, What to Expect, and More
Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. - Abstract - Europe PMC
Characteristics of Giant Cell Arteritis Flares After Successful Treatment with Tocilizumab: Results from the Long-Term Extension of a Randomized Controlled Phase 3 Trial - ACR Meeting Abstracts
Giant-Cell Arteritis and Polymyalgia Rheumatica | NEJM
Polymyalgia Rheumatica & Giant-cell Arteritis - ppt video online download
How to Manage Polymyalgia Rheumatica - Page 4 of 4 - The Rheumatologist
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial | Trials | Full Text